STOMACH AND DUODENUM: Edited by Mitchell L. SchubertAn update in the endoscopic management of gastric cancerHan, Samuel; Hsu, Andrew; Wassef, Wahid Y.Author Information Division of Gastroenterology, University of Massachusetts Medical School, Worcester, Massachusetts, USA Correspondence to Dr Wahid Y. Wassef, MD, 55 Lake Avenue North, Worcester, MA 01655, USA. Tel: +1 508 334 2846; fax: +1 508 856 3981; e-mail: [email protected] Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (www.co-gastroenterology.com). Current Opinion in Gastroenterology: November 2016 - Volume 32 - Issue 6 - p 492-500 doi: 10.1097/MOG.0000000000000318 Buy SDC Metrics Abstract Purpose of review Gastric cancer remains a leading cause of mortality worldwide and gastroenterologists are playing an increasingly larger role in its management. This article reviews the endoscopic management of gastric cancer, with emphasis on recent advances in the field. Recent findings Long-term studies comparing surgery and endoscopic resection for early gastric cancer have shown no difference in 10-year survival rates. Second-look endoscopy, performed 2 days after endoscopic submucosal dissection (ESD) to address the concern of delayed bleeding, may not affect rebleeding rates. Magnesium, proton pump inhibitors, and bupivacaine may help reduce post-ESD pain. New devices such as the Clutch Cutter and EndoLifter may help make ESD easier and safer. Summary Endoscopic therapy for early gastric cancer is becoming increasingly popular and innovations are constantly being made to improve technique and technology. This review focuses on the latest approaches to the endoscopic management of gastric cancer. Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.